AST SpaceMobile (NASDAQ: ASTS) is building a space-based cellular broadband network designed to connect directly to unmodified smartphones, making it one of the most closely watched names in the market.
Shares surged 9.39% intraday to $61.04, even as the stock remains down 23.17% year to date, a disconnect that has traders reassessing whether the selloff has gone too far.
The company’s Q2 report was a clear stumbling block, with revenue of $31.5 million coming in below the $34.40 million consensus estimate that analysts had been expecting.
A $125.9 million loss tied to the BB7 launch incident weighed heavily on GAAP earnings per share, pushing results well beneath expectations and rattling investor confidence.
Shares are down 10.01% over the past week and 5.39% over the past month, compounding a difficult stretch for shareholders who had bid the stock sharply higher earlier in the cycle.
A Pomerantz Law Firm investigation announced in August added another layer of uncertainty, and with a beta of 2.75, the stock has proven capable of violent moves in both directions.
Wall Street’s consensus analyst price target stands at $78.48, supported by a ratings breakdown of 1 strong buy, 3 buys, 7 holds, 1 sell, and 1 strong sell, reflecting a cautious majority view.
CEO Abel Avellan reinforced the company’s commercial ambitions directly to investors, stating: “We are on the cusp of commercial deployment as we prepare to scale our space-based service to everyday unmodified smartphones.”
Avellan also confirmed a target of approximately 45 BlueBird satellites in orbit by early 2027, a milestone that would mark a critical step toward generating meaningful recurring revenue.
The company holds a $1.3 billion contracted revenue backlog, a $1 billion Japan J-LEO award, and has reiterated 2026 revenue guidance in the range of $150 million to $200 million.
A Barron’s piece this week argued that ASTS could follow Voyager Technologies higher as post-earnings space sector names undergo a broader rerating by institutional investors.
Reaching $120 from the current price of $61.04 would require a gain of 96.6%, an aggressive target but one that sits within the implied volatility range of a stock carrying a 2.75 beta.
The 52-week range of $36.08 to $133.86 illustrates just how wide the market’s valuation dispersion remains for a pre-profit constellation builder of this kind.
With a negative forward EPS of $2.13, traditional price-to-earnings analysis is not applicable, meaning contracted backlog and commercial deployment timelines carry far more weight in any serious valuation framework.
Three conditions would need to align for $120 to become reality: commercial beta service launching in late 2026, the BlueBird 14 to 46 production cadence holding firm, and government contracts converting from development awards into recurring program revenue.
The primary downside risk remains another launch incident that pushes the constellation timeline further out, which would force a significant reassessment of near-term revenue expectations.
Over five years, ASTS has returned 350.73%, and over the past decade the stock has delivered gains of 471.14%, reflecting the extraordinary long-run upside that has kept speculative investors engaged.
Given the high beta, the pre-revenue-scale business model, and the binary nature of launch execution, ASTS is best approached as a speculation-sleeve holding sized with discipline rather than a core portfolio position.
